VAERS Explorer
Back to explore

Report #2846932

Received Jun 23, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
Age unknown
State
TN
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2——

Symptoms (1)

Malaise

Symptom narrative

He reports not feeling well for the evening after dose number 2; This non-serious case was reported by a consumer via sales rep and described the occurrence of feeling unwell in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose on an unknown date). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced feeling unwell (Verbatim: He reports not feeling well for the evening after dose number 2). The outcome of the feeling unwell was not reported. It was unknown if the reporter considered the feeling unwell to be related to Shingrix. It was unknown if the company considered the feeling unwell to be related to Shingrix. Additional Information: GSK receipt date: 12-JUN-2025 The patient's age was approximately of 64 years. Patient has had both doses of Shingrix. He reported not feeling well for the evening after dose number 2.